The Immunoreceptors and Immunotherapy Conference
July 17–21, 2022
New Orleans, LA
July 17-21, 2022
Immunoreceptors play a central role in cancer, autoimmunity, and infectious diseases, while immunotherapy is the rapidly expanding ﬁeld focused on meeting these challenges and changing people’s lives in the clinic. The meeting program addresses new directions in the ﬁeld by featuring the best science related to immune receptor function, immune cell signaling, and developing immunotherapy approaches.
The conference brings together international scientists from academia, government, and industry to discuss the very latest developments in the areas of immunoreceptors and immunotherapy.
Have questions about the conference? Email us at firstname.lastname@example.org.
Conference sessions will present the latest research and foster discussion on:
- Fc Receptors: Mouse to Man
- Antibodies: The Natural and Unnatural
- B-cell Receptors: Antigen to Antibody
- T-cell Receptors: Complex Signaling
- Costimulatory Receptors: Stepping on the Gas
- Inhibitory Receptors: Beyond PD-1
- Autoimmunity and Immune Dysfunction
- Immunotherapy: Where Now?
The conference covers eight oral sessions—32 invited speakers and 16 short talks selected from abstracts—and two interactive poster sessions. For trainees and junior faculty, the conference features three "Meet the Expert" lunch sessions with experts in the ﬁeld offering career and scientiﬁc advice, and the highly popular Career Development Workshop, “Choosing Your Career Destination and How to Not Get Lost On the Way,” an interactive questions and answers session with experts from academia and industry.
View the preliminary agenda.
Stephen Beers, PhD
Diane Lidke, PhD
Invited Speakers: $1099
Invited Speakers: $1099
Online or by phone at 1-877-408-9661 (mention “2022 FASEB Conference” for the discounted rate).
Be in the center of activity: Enjoy quick and easy access to all conference functions and networking opportunities.
Additional protection: FASEB may be able to assist you with any issues that arise with the hotel.
Funding for this conference was made possible [in part] by 1R13AI169682 from the National Institute of Allergy and Infectious Diseases. The views expressed in written conference materials or publications and by speakers and moderators do not necessarily reflect the official policies of the Department of Health and Human Services; nor does mention of trade names, commercial practices, or organizations imply endorsement by the U.S. Government.